These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27157997)

  • 21. Re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur urol 2007;52:1663-9.
    Boscolo-Berto R; Galfano A; Iafrate M
    Eur Urol; 2008 Aug; 54(2):469-70; author reply 471. PubMed ID: 18299171
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Steiner T, Knels R, Schubert J. Prognostic significance of tumor size in patients after tumour nephrectomy for localised renal cell carcinoma. Eur Urol 46;2004:327-30.
    Bogdanovic J
    Eur Urol; 2005 Feb; 47(2):266-7. PubMed ID: 15661427
    [No Abstract]   [Full Text] [Related]  

  • 23. Reply to Patrick O. Richard, Micheal A.S. Jewett and Antonio Finelli's Letter to the Editor re: Alexander Kutikov, Marc C. Smaldone, Robert G. Uzzo, Miki Haifler, Gennady Bratslavsky, Bradley C. Leibovich. Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol 2016;70:403-6.
    Kutikov A; Uzzo RG; Smaldone MC; Haifler M; Bratslavsky G; Leibovich BC
    Eur Urol; 2017 Feb; 71(2):e47-e48. PubMed ID: 27436159
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Felix K.-H. Chun, Thomas Steuber, Andreas Erbersdobler, et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 2006;49:820-26.
    Beckley I; Khan MA
    Eur Urol; 2007 Oct; 52(4):1270; author reply 1271. PubMed ID: 17611016
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Massimiliano Spaliviero, Bing Ying Poon, Christoph A. Karlo, et al. An Arterial Based Complexity (ABC) Scoring System to Assess the Morbidity Profile of Partial Nephrectomy. Eur Urol 2016;69:72-9.
    Giannarini G; Crestani A; Porzionato A; Macchi V; Ficarra V
    Eur Urol; 2016 Mar; 69(3):e53-4. PubMed ID: 26489475
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: Vincent Cloutier, Umberto Capitanio, Laurent Zini, et al. Thirty-day mortality after nephrectomy: clinical implications for informed consent. Eur urol 2009;56:998-1005.
    Campodonico F; Capponi G; Maffezzini M
    Eur Urol; 2009 Dec; 56(6):e45-6; author reply e47. PubMed ID: 19307052
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Paul L. Crispen, Michael L. Blute. Do percutaneous renal tumor biopsies at initial presentation affect treatment strategies? Eur Urol 2009;55:307-9.
    Park BK
    Eur Urol; 2009 Jun; 55(6):e105-6. PubMed ID: 19297078
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: Raj Satkunasivam, Sheaumei Tsai, Sumeet Syan, et al. Robotic Unclamped "Minimal-margin" Partial Nephrectomy: Ongoing Refinement of the Anatomic Zero-ischemia Concept. Eur Urol 2015;68:705-12.
    Minervini A; Campi R; Serni S; Carini M
    Eur Urol; 2016 Aug; 70(2):e47-50. PubMed ID: 26778463
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Blanchard P; Briganti A; Bossi A
    Eur Urol; 2016 Jul; 70(1):e15-e16. PubMed ID: 26922406
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Parker C
    Eur Urol; 2016 Jul; 70(1):e17. PubMed ID: 26928379
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Ost P; Ghadjar P
    Eur Urol; 2016 Jul; 70(1):e11-e12. PubMed ID: 26928380
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Froehner M; Wirth MP
    Eur Urol; 2016 Jul; 70(1):e9. PubMed ID: 26935557
    [No Abstract]   [Full Text] [Related]  

  • 33. Reply to Philipp Dahm, Vikram Narayan, and Jae Hung Jung's Letter to the Editor re: Richard J. Sylvester, Steven E. Canfield, Thomas B.L. Lam, et al. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree. Eur Urol 2017;71:811-9.
    Lam TBL; Sylvester RJ; Canfield SE; Marconi L; MacLennan S; Yuan Y; Omar MI; N'Dow J
    Eur Urol; 2017 Oct; 72(4):e93-e94. PubMed ID: 28427786
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.
    Zhou X; Han X
    Eur Urol; 2019 Jul; 76(1):e15. PubMed ID: 30948226
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Marco Borghesi, Hashim Ahmed, Robert Nam, et al. Complications After Systematic, Random, and Image-guided Prostate Biopsy. Eur Urol 2017;71:353-65.
    Grummet J; Pepdjonovic L; Moon D
    Eur Urol; 2017 May; 71(5):e143-e144. PubMed ID: 28029398
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Massimiliano Spaliviero, Nicholas E. Power, Katie S. Murray, et al. Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial. Eur Urol 2018;73:53-9.
    Dalela D; Abdollah F; Rogers C
    Eur Urol; 2018 Aug; 74(2):e48-e49. PubMed ID: 29724500
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: Eduard Roussel, Giovanni Tasso, Riccardo Campi, et al. Surgical Management and Outcomes of Renal Tumors Arising from Horseshoe Kidneys: Results from an International Multicenter Collaboration. Eur Urol 2021;79:133-40.
    Yang K; Li X; Zhou L
    Eur Urol; 2021 Jul; 80(1):e30-e31. PubMed ID: 33941400
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
    Gregucci F; Carbonara R; Fiorentino A
    Eur Urol; 2020 Sep; 78(3):e114-e115. PubMed ID: 32534911
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
    Funada S; Yoshioka T; Luo Y
    Eur Urol; 2020 Sep; 78(3):e118-e119. PubMed ID: 32682614
    [No Abstract]   [Full Text] [Related]  

  • 40. Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention.
    Menogue SR; O'Brien BA; Brown AL; Cohen RJ
    BJU Int; 2013 Apr; 111(4 Pt B):E146-51. PubMed ID: 22805186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.